MedPath

Adrenalin

Adrenalin®(epinephrine injection)1 mg/mL

Approved
Approval ID

b293ad8e-7055-4a95-a130-9d7d74f19eab

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 12, 2023

Manufacturers
FDA

Henry Schein, Inc.

DUNS: 012430880

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

epineprine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0404-9810
Application NumberNDA204200
Product Classification
M
Marketing Category
C73594
G
Generic Name
epineprine
Product Specifications
Route of AdministrationINTRAMUSCULAR, SUBCUTANEOUS, INTRAVENOUS
Effective DateJanuary 7, 2022
FDA Product Classification

INGREDIENTS (8)

EPINEPHRINEActive
Quantity: 1 mg in 1 mL
Code: YKH834O4BH
Classification: ACTIB
SODIUM METABISULFITEInactive
Quantity: 0.457 mg in 1 mL
Code: 4VON5FNS3C
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 7.3 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Quantity: 1 mg in 1 mL
Code: 55X04QC32I
Classification: IACT
TARTARIC ACIDInactive
Quantity: 2.25 mg in 1 mL
Code: W4888I119H
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 0.20 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.